The conduct and management of clinical trials for antibacterials and antifungals requires the services of a laboratory with microbiology capabilities for bacteria and fungi.
Medpace is partnered with JMI Laboratories, a world-reknown specialist in anti-infectives (antibacterials
and antifungals) research. Their surveillance
and clinical trial microbiology capabilites are unrivaled, and are further supported by molecular biology techniques and assays. These capabilites are a powerful combination with
Medpace's regulatory medical writing expertise.
Downloads and Links
Medpace physicians and professional staff have extensive experience designing
and conducting clinical trials and
understand the issues from the perspective of the sponsor, the clinical investigator, the
scientific leader, and the reviewer at the regulatory agencies. Medpace brings
these perspectives to each clinical trial that we conduct. Our experience in
anti-infective drug and vaccine development spans adult and pediatric populations.
Medpace supports our sponsors who are advancing new anti-infective drugs, including anti-virals, anti-bacterials, anti-fungals,
and vaccines through specialized expertise in the design and management of anti-infective programs that maximize a drug candidate’s
probability of success. Medpace and its Infectious Disease team have broad experience conducting anti-infective clinical trials.
These dedicated teams with broad experience are focused on serving sponsors in all their clinical development needs.
Strong Lab Partnerships
Medpace brings exceptional expertise to infectious disease projects with strong and novel partnering relationships.
Medpace has partnered with key specialty laboratories to provide specific state-of–the-art microbiology and molecular infectious disease
capabilities to complement expert central laboratory services already provided by
Medpace Reference Laboratories.
With an unprecedented reputation in microbiology specialization,
JMI Laboratories is known for its academic rigor and infectious diseases laboratory excellence.
JMI provides not only a library of existing samples of assays for our sponsors’ studies but is constantly pushing its technological
limits and capacity to bring in the newest assays. This unified laboratory partnership interfaces with another of strategic partner,
the Institute for Clinical Pharmacodynamics (ICPD), to coordinate the planning, monitoring, analyses, and reporting of our studies.
ICPD is a world recognized expert in PK/PD modeling. Combining these unique relationships with other Medpace full-service business
units improve the efficiency of Sponsors programs.
- Hepatitis B virus
- Hepatitis C virus
- RSV Bronchiolitis Obliterans Syndrome
- Acute bacterial skin and soft structure infections
- Acute and chronic bronchitis
- Community-acquired pneumonia
- Hospital-acquired pneumonia and ventilator-associated pneumonia
- Complicated intra-abdominal infections
- Urinary tract infections (uncomplicated and complicated)
- Sexually transmitted diseases (including HSV and HPV)
- Bacterial endocarditis
- Bacterial conjunctivitis
- Severe whooping cough (Bordetella pertussis)
- Clostridium difficile associated disease (CDAD)
- Multi-drug resistant (MDR) pathogens
- Staphylococcus aureus including MRSA
- Fungal infections
>> Click here to learn more
about Medpace's capabilities and therapeutic expertise in infectious disease and